24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
66.67% |
|
ENZYME DYNAMICS |
26.98% |
|
PEPTIDOMIMETIC CD40L BINDING |
3.17% |
|
CANCER |
3.17% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
75.67% |
|
ENZYME DYNAMICS |
22.06% |
|
ATWRI1 MUTANT SCREENING |
1.44% |
|
PEPTIDOMIMETIC CD40L BINDING |
.41% |
|
CANCER |
.41% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
75.52% |
|
ENZYME DYNAMICS |
8.09% |
|
INFLUENZA |
6.16% |
|
CANCER |
4.46% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
2.08% |
|
RCA STABILITY SIMULATIONS |
1.4% |
|
NIPAH VIRUS DECOY PROTEIN DYNAMICS |
1.18% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
.52% |
|
MEMBRANE TRANSPORT |
.27% |
|
ATWRI1 MUTANT SCREENING |
.17% |
|
RCA OLIGOMER STABILITY SIMULATIONS |
.1% |
|
PEPTIDOMIMETIC CD40L BINDING |
.05% |